Follow-The-Filings

Security

Aura Biosciences Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 2 new max 0.0% (Vanguard Group Inc.)

owners 8
max % 0.0%
tracked value $29M
qoq N 2 A 3 R 3

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 2,936,538 $16M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 1,097,627 $7M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 557,654 $4M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 102,100 $683 hist
Ken Fisher - Fisher Asset Management, LLC 2026 Q1 0.0% New 0.0% 83,508 $559 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 46,143 $309 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 21,708 $145 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 12,503 $84 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$76.41M -$86.92M -$106.19M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $231.79M $160.62M $149.74M
Total non-current assets * $23.28M $21.88M $19.69M
Total assets $255.08M $182.5M $169.43M
Total current liabilities $12.36M $14.91M $18.38M
Total non-current liabilities * $16.87M $15.62M $14.13M
Total equity $225.85M $151.97M $136.91M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$63.85M -$79.8M -$84.74M
Cash from investing -$113.96M $68.82M $35.6M
Cash from financing $97.29M $1.6M $77.16M
Net change in cash * -$80.52M -$9.39M $28.01M

ownership over time

filing count by report period · click a bar for that quarter’s holders